Related Experiment Video
Updated: Jun 22, 2025
07:49
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.3K
[New pacing strategies for heart failure]
Sebastian E Beyer1, Guram Imnadze1, Philipp Sommer2,3
1Klinik für Elektrophysiologie, Herz- und Diabeteszentrum NRW, Ruhr Universität Bochum, Georgstr. 11, 32545, Bad Oeynhausen, Deutschland.
Innere Medizin (Heidelberg, Germany)
|July 5, 2024
Summary
Left bundle branch pacing offers a more effective alternative to traditional cardiac resynchronization therapy (CRT) for heart failure patients with reduced ejection fraction and left bundle branch block. This advanced technique improves outcomes and should be considered an initial treatment strategy.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Cardiac resynchronization therapy (CRT) improves outcomes in heart failure patients with systolic dysfunction and left bundle branch block.
- Traditional CRT via coronary sinus leads has limitations, including venous access issues, rising thresholds, and a significant non-response rate (up to 30%).
- Direct conduction system pacing, specifically left bundle branch pacing (LBBP), offers a more physiological approach.
Purpose of the Study:
- To evaluate the efficacy and safety of left bundle branch pacing (LBBP) as an alternative to conventional CRT.
- To compare LBBP with standard CRT in patients with specific cardiac conditions.
Main Methods:
- LBBP involves pacing the left bundle branch by advancing a lead into the right ventricle and deep into the interventricular septum.
- Utilized observational studies and small randomized trials to assess outcomes.
Main Results:
- LBBP demonstrates a high success rate (>90%) due to the broad target area of the left bundle branch.
- Studies show LBBP leads to greater QRS duration reduction, improved systolic function, and lower heart failure hospitalization rates compared to coronary sinus-based CRT.
- Findings are supported by initial randomized trial data.
Conclusions:
- Left bundle branch pacing is a highly effective technique for cardiac resynchronization.
- LBBP should be considered not only as a rescue therapy but increasingly as a primary pacing strategy for eligible patients.
- Further results from large randomized trials are anticipated to solidify LBBP's role in clinical practice.
Keywords:
Biventricular pacingBundle of HisCardiac conduction systemCardiac resynchronization therapyLeft bundle branch pacingMore Related Videos
Related Concept Videos
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:26Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:22Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362